Video LIFE SCIENCES | DAILY NEWS | APRIL 16, 2025 | PHARMASHOTSByRidhi RastogiApril 16, 20250Comments
News Merck Signs a ~$493M Deal with Cyprumed to Develop Oral Peptide TherapeuticsByRidhi RastogiApril 15, 20250Comments
News Celltrion’s Yuflyma (Biosimilar, Humira) Receives the US FDA’s Interchangeability DesignationByRidhi RastogiApril 15, 20250Comments
News The US FDA Grants Conditional Approval to Initiate Second Cohort of the EFS Study of CARMAT’s Aeson Artificial HeartByRidhi RastogiApril 15, 20250Comments
News Bruno Vision Care’s Deseyne Contact Lens Secures the US FDA’s Approval for Dry Eye DiseaseByRidhi RastogiApril 15, 20250Comments
News Cue Biopharma Collaborates with Boehringer Ingelheim to Develop B cell-Targeting Bispecifics for Autoimmune and Inflammatory DiseasesByRidhi RastogiApril 15, 20250Comments
News Intas Pharmaceuticals Acquires Coherus BioSciences’ Udenyca Business (Biosimilar, Neulasta)ByRidhi RastogiApril 15, 20250Comments
Video LIFE SCIENCES | DAILY NEWS | APRIL 15, 2025 | PHARMASHOTSByRidhi RastogiApril 15, 20250Comments
